BioSpace News Archive

NeuroVive today announced that NeuroVive and Ramin Massoumi at Lund University have been granted 2.5 MSEK from the Swedish Foundation for Strategic Research for an Industrial PhD to study the role of cyclophilins in liver cancer.

Bracco Imaging today announced the acquisition of SurgVision, a high-tech start-up focused on developing a real-time Fluorescence Image Guided Surgery platform combining targeted imaging agent and a device for efficient tumors visualization during oncology surgical procedures.

LYNPARZA has the potential to offer a new treatment option for patients with germline BRCA-mutated, HER2-negative metastatic breast cancer.

Vir Biotechnology, Inc. today announced agreements with Humabs BioMed SA, Alnylam Pharmaceuticals, Inc., and Visterra, Inc., as well as four leading academic research institutions.

In this landmark study, a follow-up to BluePrint 1, a global team of thoracic pathologists reviewed the immunostains of five clinical grade PD-L1 IHC assays (22C3, 28-8, SP142, SP263, and 73-10).

Graham Miao, Ph.D., President and Chief CFO, will leave the Company at the end of the year in order to pursue other opportunities.

[18-October-2017] FALL RIVER, Mass., Oct. 18, 2017 /PRNewswire/ -- Millstone Medical announced today the addition of on-site Microbiologist, Joshua Browning, to their Fall River sterile packaging facility. Joshua previously served as a Quality Control Analyst, Microbiology at Nanotherapeutics where he executed facility process qualifications and validations of ISO 7 and ISO 8 cleanro

Ms. Fish was most recently the Chief Human Resources Officer for Marlin Equity Partners, a private equity firm.

Mutabilis announces its selection by the European ENABLE project (European Gram-negative Antibacterial Engine), which aims to improve the development of antibiotics against infections caused by multiresistant Gram-negative bacteria.

Innoviva announced today that it will report financial results for the third quarter ended September 30, 2017 after market close on Wednesday, October 25, 2017. Following the earnings release, Innoviva management will host a webcast and conference call at 5:00 p.m. EDT/2:00 p.m. PDT to discuss the financial results and provide a corporate update.